Interaction of [VO₂(MA)₂]⁻ with model membranes: relevance to insulin enhancing effects of BMOV and its oxidized form
| dc.contributor.author | Schoeberl, Samantha Kay, author | |
| dc.contributor.author | Roess, Deborah, advisor | |
| dc.contributor.author | Graham, James, committee member | |
| dc.contributor.author | Crans, Debbie, committee member | |
| dc.date.accessioned | 2022-04-21T16:52:58Z | |
| dc.date.available | 2022-04-21T16:52:58Z | |
| dc.date.issued | 2010 | |
| dc.description | Covers not scanned. | |
| dc.description | Print version deaccessioned 2022. | |
| dc.description.abstract | Anti-diabetic vanadium-containing compounds and salts reportedly have effects on the overall organization of the cytoskeleton and the plasma membrane of cells. For ligand-mediated signaling, appropriate cytoskeletal and membrane lipid organization is essential for down-stream signaling to occur. A number of vanadium-containing compounds and salts are of interest because of their effects on these important cellular structures. Promising results in regulating diabetic symptoms such as glucose and lipid metabolism have been shown to result from the use of various anti-diabetic vanadium drugs. Their effects on the cytoskeleton and plasma membrane are reviewed Chapter I. Due to the importance of membrane interactions of vanadium-containing compounds with insulin-enhancing activity in ligand-mediated signaling, two simple membrane model systems were used to investigate the interactions of an oxidized metabolite of bis(maltolato)oxovanadium(IV) with model lipid interfaces. Studies were carried out using multinuclear NMR spectroscopy with a focus on 1H NMR techniques. In Chapter II we demonstrate that there were slight changes in 1H NMR spectra indicating that this BMOV metabolite was able to penetrate the lipid interface. These findings are important in understanding the pharmacologic mechanism of action of this anti-diabetic compound in cells and intact animals. | |
| dc.format.medium | masters theses | |
| dc.identifier.uri | https://hdl.handle.net/10217/234769 | |
| dc.language | English | |
| dc.language.iso | eng | |
| dc.publisher | Colorado State University. Libraries | |
| dc.relation | Catalog record number (MMS ID): 991014451169703361 | |
| dc.relation | QP572.I5 S36 2010 | |
| dc.relation.ispartof | 2000-2019 | |
| dc.rights | Copyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright. | |
| dc.subject.lcsh | Insulin -- Pathophysiology | |
| dc.subject.lcsh | Vanadium compounds | |
| dc.subject.lcsh | Diabetes -- Research | |
| dc.subject.lcsh | Cell membranes -- Effect of drugs on | |
| dc.title | Interaction of [VO₂(MA)₂]⁻ with model membranes: relevance to insulin enhancing effects of BMOV and its oxidized form | |
| dc.type | Text | |
| dcterms.rights.dpla | This Item is protected by copyright and/or related rights (https://rightsstatements.org/vocab/InC/1.0/). You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). | |
| thesis.degree.discipline | Biomedical Sciences | |
| thesis.degree.grantor | Colorado State University | |
| thesis.degree.level | Masters | |
| thesis.degree.name | Master of Science (M.S.) |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ETDF_2010_Summer_Schoeberl_Samantha_Kay.pdf
- Size:
- 23.94 MB
- Format:
- Adobe Portable Document Format